Works matching IS 0167594X AND DT 2015 AND VI 121 AND IP 2

Results: 24

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 331, doi. 10.1007/s11060-014-1636-6

By:

Wen, Qiuting;
Jalilian, Laleh;
Lupo, Janine;
Molinaro, Annette;
Chang, Susan;
Clarke, Jennifer;
Prados, Michael;
Nelson, Sarah

Publication type:

Article

Chemotherapy-induced peripheral neuropathies in hematological malignancies.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 229, doi. 10.1007/s11060-014-1632-x

By:

Jongen, Joost;
Broijl, Annemiek;
Sonneveld, Pieter

Publication type:

Article

Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 303, doi. 10.1007/s11060-014-1633-9

By:

Amin, Amr;
Mustafa, M.;
Abd El-Hadi, E.;
Monier, A.;
Badwey, A.;
Saad, E.

Publication type:

Article

Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 311, doi. 10.1007/s11060-014-1634-8

By:

Kim, Hong;
Kim, Se-Hwan;
Lee, Jung-Il;
Seol, Ho;
Nam, Do-Hyun;
Kim, Sung;
Park, Kwan;
Kim, Jong;
Kong, Doo-Sik

Publication type:

Article

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 319, doi. 10.1007/s11060-014-1635-7

By:

Hunn, Martin;
Bauer, Evelyn;
Wood, Catherine;
Gasser, Olivier;
Dzhelali, Marina;
Ancelet, Lindsay;
Mester, Brigitta;
Sharples, Katrina;
Findlay, Michael;
Hamilton, David;
Hermans, Ian

Publication type:

Article

Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 239, doi. 10.1007/s11060-014-1630-z

By:

Tanaka, Shingo;
Nakada, Mitsutoshi;
Yamada, Daisuke;
Nakano, Ichiro;
Todo, Tomoki;
Ino, Yasushi;
Hoshii, Takayuki;
Tadokoro, Yuko;
Ohta, Kumiko;
Ali, Mohamed;
Hayashi, Yutaka;
Hamada, Jun-ichiro;
Hirao, Atsushi

Publication type:

Article

PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 251, doi. 10.1007/s11060-014-1637-5

By:

Mathios, Dimitrios;
Ruzevick, Jacob;
Jackson, Christopher;
Xu, Haiying;
Shah, Sagar;
Taube, Janis;
Burger, Peter;
McCarthy, Edward;
Quinones-Hinojosa, Alfredo;
Pardoll, Drew;
Lim, Michael

Publication type:

Article

Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 341, doi. 10.1007/s11060-014-1638-4

By:

Walbert, Tobias;
Mendoza, Tito;
Vera-Bolaños, Elizabeth;
Acquaye, Alvina;
Gilbert, Mark;
Armstrong, Terri

Publication type:

Article

Classification of tumor area using combined DCE and DSC MRI in patients with glioblastoma.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 349, doi. 10.1007/s11060-014-1639-3

By:

Artzi, Moran;
Blumenthal, Deborah;
Bokstein, Felix;
Nadav, Guy;
Liberman, Gilad;
Aizenstein, Orna;
Ben Bashat, Dafna

Publication type:

Article

The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 359, doi. 10.1007/s11060-014-1640-x

By:

Chambless, Lola;
Kistka, Heather;
Parker, Scott;
Hassam-Malani, Laila;
McGirt, Matthew;
Thompson, Reid

Publication type:

Article

Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 365, doi. 10.1007/s11060-014-1641-9

By:

Taal, Walter;
Rijt, Carin;
Dinjens, Winand;
Sillevis Smitt, Peter;
Wertenbroek, Agnes;
Bromberg, Jacoline;
Heuvel, Irene;
Kros, Johan;
Bent, Martin

Publication type:

Article

Diffusion weighted MRI is a promising imaging biomarker in brain metastases.

Published in:

2015

By:

Zakaria, R.;
Jenkinson, M.

Publication type:

Letter

Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 373, doi. 10.1007/s11060-014-1644-6

By:

Kickingereder, Philipp;
Wiestler, Benedikt;
Graf, Markus;
Heiland, Sabine;
Schlemmer, Heinz;
Wick, Wolfgang;
Wick, Antje;
Bendszus, Martin;
Radbruch, Alexander

Publication type:

Article

Expert-validated CSF segmentation of MNI atlas enhances accuracy of virtual glioma growth patterns.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 381, doi. 10.1007/s11060-014-1645-5

By:

Amelot, A.;
Stretton, E.;
Delingette, H.;
Ayache, N.;
Froelich, S.;
Mandonnet, E.

Publication type:

Article

The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 261, doi. 10.1007/s11060-014-1646-4

By:

Zhang, Lei;
Yan, Yong;
Jiang, Ying;
Cui, Yong;
Zou, Yongxiang;
Qian, Jun;
Luo, Chun;
Lu, Yicheng;
Wu, Xiaojun

Publication type:

Article

Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 269, doi. 10.1007/s11060-014-1647-3

By:

Schneider, Kristin;
Weyerbrock, Astrid;
Doostkam, Soroush;
Plate, Karl;
Machein, Marcia

Publication type:

Article

Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid Tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 389, doi. 10.1007/s11060-014-1648-2

By:

Weber, Damien;
Ares, Carmen;
Malyapa, Robert;
Albertini, Francesca;
Calaminus, Gabriele;
Kliebsch, Ulrike;
Mikroutsikos, Lorentzos;
Morach, Petra;
Bolsi, Alessandra;
Lomax, Tony;
Schneider, Ralf

Publication type:

Article

Comment on 'The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline' [J Neurooncol 2014; 118:435-460].

Published in:

2015

By:

Booth, Thomas;
Waldman, Adam;
Jefferies, Sarah;
Jäger, Rolf

Publication type:

Letter

Post progression survival in glioblastoma: where are we?

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 399, doi. 10.1007/s11060-014-1651-7

By:

Franceschi, Enrico;
Ermani, Mario;
Bartolini, Stefania;
Bartolotti, Marco;
Poggi, Rosalba;
Tallini, Giovanni;
Marucci, Gianluca;
Fioravanti, Antonio;
Tosoni, Alicia;
Agati, Raffaele;
Bacci, Antonella;
Pozzati, Eugenio;
Morandi, Luca;
Balestrini, Damiano;
Ghimenton, Claudio;
Crisi, Girolamo;
Brandes, Alba

Publication type:

Article

Single agent vinorelbine in pediatric patients with progressive optic pathway glioma.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 405, doi. 10.1007/s11060-014-1652-6

By:

Cappellano, Andrea;
Petrilli, Antonio;
Silva, Nasjla;
Silva, Frederico;
Paiva, Priscila;
Cavalheiro, Sergio;
Bouffet, Eric

Publication type:

Article

Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 413, doi. 10.1007/s11060-014-1653-5

By:

Jung, Tae-Young;
Lee, Ji;
Kim, Dong-Seok;
Park, Hyeon;
Kim, Chae-Yong;
Ra, Young-Shin;
Lee, Mee-Jeong;
Kim, Seong-Ho;
Baek, Hee-Jo;
Kim, Il;
Park, Kyung;
Kim, Seung-Ki

Publication type:

Article

Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 279, doi. 10.1007/s11060-014-1654-4

By:

Chao, Yuewen;
Wang, Yan;
Liu, Xuejiao;
Ma, Peng;
Shi, Yi;
Gao, Jian;
Shi, Qiong;
Hu, Jinxia;
Yu, Rutong;
Zhou, Xiuping

Publication type:

Article

Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 289, doi. 10.1007/s11060-014-1655-3

By:

Akhter, Ariz;
Masir, Noraidah;
Elyamany, Ghaleb;
Phang, Kean-Chang;
Mahe, Etienne;
Al-Zahrani, Ali;
Shabani-Rad, Meer-Taher;
Stewart, Douglas;
Mansoor, Adnan

Publication type:

Article

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 297, doi. 10.1007/s11060-014-1631-y

By:

Norden, Andrew;
Schiff, David;
Ahluwalia, Manmeet;
Lesser, Glenn;
Nayak, Lakshmi;
Lee, Eudocia;
Rinne, Mikael;
Muzikansky, Alona;
Dietrich, Jorg;
Purow, Benjamin;
Doherty, Lisa;
LaFrankie, Debra;
Pulverenti, Julee;
Rifenburg, Jennifer;
Ruland, Sandra;
Smith, Katrina;
Gaffey, Sarah;
McCluskey, Christine;
Ligon, Keith;
Reardon, David

Publication type:

Article